MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze IPX →
    • FindStock Picks / Stock Screener
    • Value · IPXIntrinsic Value Calculator
    • Invest · IPXInvestment Case
    • Hold · IPX5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
IPX stock logo

IPX

IperionX Limited

$9.96
-1.38
 (-12.17%)
Exchange:  NASDAQ
Market Cap:  334.258M
Shares Outstanding:  3.357M
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Basic MaterialsView sector performance
Industry:  Other Precious MetalsView industry performance
   
CEO:  Anastasios Arima
Full Time Employees:  28
Address: 
1092 Confroy Drive
South Boston
VA
24592
US
Website:  https://www.iperionx.com
IperionX Limited engages in the development of its mineral properties in the United States. It holds a 100% interest in the critical minerals Titan project, which has resources of titanium, zircon, and rare earth mineral resources in Tennessee, the United States. The company also engages in the production of angular and spherical titanium metal powders. It serves automotive and transport, consumer electronics, aerospace and defense, energy, medical, luxury goods, and industrial markets. The company was formerly known as Hyperion Metals Limited and changed its name to IperionX Limited in February 2022. IperionX Limited was incorporated in 2017 and is headquartered in Charlotte, North Carolina.

Click to read more…

Revenue Segmentation

🔒 You are currently logged out

Login

It’s free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
IPIPX logoIPXIperionX Limited334.3M——-75.2%
LZLZM logoLZMLifezone Metals Limited350.8M——-8.0%
ITITRG logoITRGIntegra Resources Corp.290.1M9.76.211.6%
ELELVR logoELVRElevra Lithium Limited398.0M5.7—-5.5%
ALALOY logoALOYREalloys Inc.264.0M——-81.7%
VOVOXR logoVOXRVox Royalty Corp.262.0M5.07.710.5%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

No earnings call materials on file for this symbol yet.

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202420252026
Revenue000
Gross Profit-648.218-2,274.382-4,369.126
EBITDA-21,971.417-36,997.519-65,650.498
Operating Income-22,457.210-39,271.901-70,019.624
Net Income-22,226.061-35,348.675-67,066.025

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202420252026
Total Assets55,435.894105,034.979105,751.025
Total Liabilities4,096.29912,590.98017,451.336
Total Stockholders Equity51,339.59592,443.99988,299.689
Total Debt1,490.6733,934.5824,158.979
Cash and Cash Equivalents33,157.35654,814.12535,244.220

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202420252026
Operating Cash Flow-18,675.271-21,797.685-45,155.482
Capital Expenditure-8,069.652-17,607.677-17,860.568
Free Cash Flow-26,744.923-39,405.362-63,016.050
Net Income-21.843-35,348.675-67,066.025
Net Change in Cash21,219.41521,656.769-19,569.905

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2031Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)155,302.312Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)920,691.720Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)587,100Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)2,749.478Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)6,062.709Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)4,618.640Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)67.771Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)2,685.223Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)1,544.409Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)0Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)0Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)0.460Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)0.800Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)0.020Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)1Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)1Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
0  ?P/S
 (TTM)
: 
0
?Net Income
 (TTM)
: 
-21.924M  ?P/E
 (TTM)
: 
-5.51
?Enterprise Value
 (TTM)
: 
367.055M  ?EV/FCF
 (TTM)
: 
-7.94
?Dividend Yield
 (TTM)
: 
0%  ?Payout Ratio
 (TTM)
: 
0%
?ROE
 (TTM)
: 
-67.95%  ?ROIC
 (TTM)
: 
-75.17%
?Net Debt
 (TTM)
: 
-31.667M  ?Debt/Equity
 (TTM)
: 
0.05
?P/B
 (TTM)
: 
4.23  ?Current Ratio
 (TTM)
: 
3.24

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
N/AResearch AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates IPX intrinsic value between $0.36 – $0.79 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate IPX Intrinsic Value

Common questions about IPX valuation

Is IperionX Limited (IPX) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for IperionX Limited (IPX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is IPX a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether IPX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is IPX’s P/E ratio?

You can see IPX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for IPX?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is IPX a good long-term investment?

Whether IPX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for IperionX Limited

  • IperionX Limited intrinsic value calculatorEstimate what the business is worth
  • IperionX Limited 5-year outlookWhat has to go right, and what could go wrong
IPX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-12.17
MarketSnap

Trading Metrics:

Open: 11.17   Previous Close: 11.34
Day Low: 9.92   Day High: 11.19
Year Low: 9.92   Year High: 61.45
Price Avg 50: 15.96   Price Avg 200: 27.67
Volume: 686636   Average Volume: 295794

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

IperionX: A Buy On America's Emerging Titanium Supply Chain
10-11-2026 12:51
IperionX: A Buy On America's Emerging Titanium Supply Chain
IPX1031 Named Best Overall 1031 Exchange Company by Fit Small Business for Fifth Consecutive Year
27-08-2026 14:10
IPX1031 Named Best Overall 1031 Exchange Company by Fit Small Business for Fifth Consecutive Year
IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law
17-08-2026 16:28
IPX Investors Have Opportunity to Join IperionX Limited Fraud Investigation with SBS Law
IperionX Limited (IPX) Shareholder/Analyst Call Transcript
04-08-2026 22:40
IperionX Limited (IPX) Shareholder/Analyst Call Transcript
IperionX Announces Pricing of Public Offering of American Depositary Shares
07-07-2026 19:51
IperionX Announces Pricing of Public Offering of American Depositary Shares
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations
29-06-2026 03:00
Zambon and Amneal Announce Positive CHMP Opinion for Hopledo® (IPX203) for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze IPX →
    • FindStock Picks / Stock Screener
    • Value · IPXIntrinsic Value Calculator
    • Invest · IPXInvestment Case
    • Hold · IPX5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.